China Medical University, China
Clinical trials sponsored by China Medical University, China, explained in plain language.
-
Triple attack: virus therapy plus two drugs targets liver metastases in colorectal cancer
Disease control Not yet recruitingThis early-stage study tests a new treatment for people with colorectal cancer that has spread to the liver and hasn't responded to standard therapies. The treatment combines a modified virus (BioTTT001) that targets cancer cells, with two drugs (toripalimab and regorafenib) that…
Phase: PHASE1 • Sponsor: China Medical University, China • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New combo therapy aims to keep lung cancer at bay longer
Disease control Not yet recruitingThis study tests a maintenance therapy for people with extensive small cell lung cancer that has responded to initial treatment. The combination includes a liposomal form of irinotecan, platinum chemotherapy, an immune checkpoint inhibitor, and anlotinib. The goal is to see if th…
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated May 22, 2026 13:54 UTC